D9446

L-DOPS

≥98% (HPLC)

• 동의어(들): Droxidopa, L-threo 3,4-Dihydroxyphenylserine
• 실험식(Hill 표기법): C₉H₁₁NO₅
• CAS Number: 23651-95-8
• Molecular Weight: 213.19
• MDL number: MFCD00799030
• UNSPSC 코드: 12352200
• PubChem Substance ID: 329798902
• NACRES: NA.77

속성

• Quality Level: 100
• 분석: ≥98% (HPLC)
• 양식: powder
• 저장 조건: desiccated
• 색상: white to tan
• solubility: DMSO: ≥3 mg/mL
• 저장 온도: −20°C
• SMILES string: N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O
• InChI: 1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1
• InChI key: QXWYKJLNLSIPIN-JGVFFNPUSA-N
• 유전자 정보: human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152), ADRB1(153), ADRB2(154), ADRB3(155)

설명

일반 설명

L-DOPS, also called L-threo 3,4-Dihydroxyphenylserine or droxidopa is a catecholamine. L-DOPS has many clinical advantages and may be useful for treating norepinephrine deficiency. It is used for treating neurogenic orthostatic hypotension and improves norepinephrine levels. L-DOPS mediates reduction of amyloid plaques and could have a therapeutic potential for treating amyloid pathology.

애플리케이션

L-DOPS has been administered for clinical trial studies in mice with amyloid pathology.

생화학적/생리학적 작용

L-DOPS is a norepinephrine precursor in vivo.

특징 및 장점

This compound is featured on the Dopamine, Norepinephrine and Epinephrine Synthesis page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H315,H319,H335
• 예방조치 성명서: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 표적 기관: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable